Indegene Ltd.

NSE: INDGN | BSE: 544172 | ISIN: INE065X01017 | Industry: Healthcare Services
| Mid-range Performer
531.1000 -10.35 (-1.91%)
NSE Jun 23, 2026 15:31 PM
Volume: 227.7K
 

logo
Indegene Ltd.
03 May 2024
531.10
-1.91%
HDFC Securities
IPO Note - Indegene Limited Indegene Limited (IL) provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products
Number of FII/FPI investors increased from 143 to 150 in Mar 2026 qtr.
More from Indegene Ltd.
Recommended